KUALA LUMPUR, July 10 -- BIA Separations, a leading bio-chromatography development and manufacturing company, has signed agreements with Bioscience companies, GeneX India Biosciences Pvt Ltd (GeneX India) and IT Technologies Pte Ltd (IT Tech).
“We are delighted to have GeneX India and IT Tech on board and look forward to jointly providing researchers and process developers across Asia with our state-of-the-art bioprocessing technologies and services, to enable the accelerated development of cell and gene based medicines,” said BIA Separations Business Development Officer, Ingo S. Nagler.
Both Companies will act as sole distributors of BIA Separations’ products and services across their respective regions of India, and Singapore and Malaysia.
BIA Separations provides research and method development services for the purification of large and complex biomolecules including those with therapeutic applications.
Through the agreements, both distributors will provide academic researchers, CMOs and biopharmaceutical companies access to BIA Separations’ proprietary CIMac™ analytical and CIMmultus™ preparative purification technologies for cell and gene therapies.
This includes viral vectors, nucleic acids, phages and exosomes, according to a statement.
-- BERNAMA
No comments:
Post a Comment